Photobiomodulation Therapy in Patients Receiving Total Knee Arthroplasty

Last updated: May 28, 2024
Sponsor: National Taiwan University Hospital Hsin-Chu Branch
Overall Status: Active - Recruiting

Phase

N/A

Condition

Inflammation

Osteoarthritis

Treatment

Photobiomodulation

Clinical Study ID

NCT06426251
111-036-F
  • Ages > 20
  • All Genders

Study Summary

Photobiomdoulation is the use of near-infrared light to relieve pain, stimulate healing and reduce inflammation. Swelling and inflammation is a common condition after orthopedics surgeries over extremity and spine. This study aim to evaluate the effect of photobiomodulation over patients after Total Knee Arthroplasty.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • total knee arthroplasty

Exclusion

Exclusion Criteria:

  • open injury

  • pregnancy

  • wound without primary closure

  • infection

  • previous surgery over surgical site

  • skin defect

Study Design

Total Participants: 15
Treatment Group(s): 1
Primary Treatment: Photobiomodulation
Phase:
Study Start date:
May 20, 2024
Estimated Completion Date:
December 31, 2027

Study Description

Patients aged over 20 after Total Knee Arthroplasty in our institution would be candidate for recruitment. The patients will be randomized to receive routine post operative care or photobiomodulation therapy. The swelling extent and subjective outcome will be recorded.

Connect with a study center

  • National Taiwan University Hospital, Hsin-Chu Branch

    Hsinchu,
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.